We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

6 hedge funds and large institutions have $130K invested in PDL BioPharma, Inc. in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 6 → 6 (0)

0% more capital invested

Capital invested by funds: $130K → $130K ($0)

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PDLI Hedge Fund Activity: Q4 2023 in Review

6 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q4 2023, worth a combined $130K — unchanged from a quarter earlier.

Fund positioning in PDLI was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 6 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $130K of PDL BioPharma, Inc. stock for Q4 2023, unchanged quarter-over-quarter.
  • 0 funds opened new PDL BioPharma, Inc. positions in Q4 2023 and 0 closed out.

Based on aggregated 13F filings for Q4 2023.